soul trial oral semaglutide cardiovascular outcomes Reduces CV Events in T2DM β (NEJM, Mar 2025) Relevant for: cardiology, diabetology, nephrology, internal medicine π§ͺ T2DM + ASCVD/CKD π Oral semaglutide 14 mg vs placebo π Semaglutide Effects on Cardiovascular Outcomes
Description
Once it finally moved, it arrived by two-day delivery, so most of the delay happened before the package ever left the pharmacy
Secure SEPA bank transfer
When you consume carbohydrates, they quickly convert to glucose in your bloodstream
The buzz around GLP-1 for weight and blood sugar management is hard to ignore, especially with GLP-1 medications
When body fat drops too low, you lose insulation, making you more sensitive to temperature drops
The drug pipelines have diversified
